Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Angiographies of the supra-aortic vessels by magnetic imaging have become common recently. So it was the purpose of this study to evaluate the imaging potential of different contrast agents.
Three contrast agents for magnetic resonance imaging are compared in angiographies of the supra-aortic arteries in a intraindividual study of 10 patients.
All applications of these contrast agents are performed with a flow of 2 ml/s. One contrast medium is applicated a second time with a reduced flow of 1 ml/s.
The angiographies of the supra-aortic vessels are evaluated by two experienced readers in a consensus reading. The signal/noise- and contrast/noise-ratio of anatomic vessel segments of the carotic and vertebral arteries are measured and compared to each other.
| Condition | Intervention | Phase |
|---|---|---|
|
Headache Epilepsy Dizziness |
Drug: Contrast agent |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Single Blind Primary Purpose: Diagnostic |
| Official Title: | Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients With Headache and Dizziness or Epilepsy and Clinical Indication for an Angiography by Magnetic Imaging |
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Headache
- Epilepsia
- Dizziness
Exclusion Criteria:
- Pregnancy
- Metal implants (e.g. pacemaker)
- Contraindication for contrast agent
- Multiple allergies
Contacts and Locations| Contact: Boris Buerke, MD | 00492518345123 | buerkeb@uni-muenster.de |
| Contact: Bernd Tombach, MD | 00492518345123 | tombach@uni-muenster.de |
| Germany | |
| University of Muenster, Dept. of Clinical Radiology | Recruiting |
| Muenster, Germany, 48129 | |
| Contact: Boris Buerke, MD 00492518345123 buerkeb@uni-muenster.de | |
| Contact: Bernd Tombach 00492518345123 tombach@uni-muenster.de | |
| Principal Investigator: Bernd Tombach, MD | |
| Sub-Investigator: Boris Buerke, MD | |
| Study Chair: | Bernd Tombach, MD | University of Muenster, Dept. of Clinical Radiology |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00132223 History of Changes |
| Other Study ID Numbers: | 0710/2004-IKR |
| Study First Received: | August 18, 2005 |
| Last Updated: | April 11, 2006 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by University Hospital Muenster:
|
magnetic imaging angiography contrast agent |
signal/noise ratio contrast/noise ratio vessel |
Additional relevant MeSH terms:
|
Dizziness Vertigo Epilepsy Headache Sensation Disorders Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
Vestibular Diseases Labyrinth Diseases Ear Diseases Otorhinolaryngologic Diseases Brain Diseases Central Nervous System Diseases Pain |
ClinicalTrials.gov processed this record on May 19, 2013